Mondelez International Forecast, price target & analysts
Mondelez International Target price 2025 - Analyst rating & recommendation
Mondelez International Classifications & Recommendation:
Mondelez International Price Target
| Target Price | $76.27 |
| Price | $61.66 |
| Potential | 23.70% |
| Number of Estimates | 31 |
| 31 Analysts have issued a price target Mondelez International 2026 . The average Mondelez International target price is $76.27. This is 23.70% higher than the current stock price. The highest price target is $92.40 49.85% , the lowest is $58.58 5.00% . | |
| A rating was issued by 34 analysts: 24 Analysts recommend Mondelez International to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Mondelez International stock has an average upside potential 2026 of 23.70% . Most analysts recommend the Mondelez International stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
29 Analysts have issued a sales forecast Mondelez International 2025 . The average Mondelez International sales estimate is $39.3b . This is 5.98% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $41.0b 10.41% , the lowest is $37.2b 0.12% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $36.4b | 1.18% |
|---|---|---|
| 2025 | $39.3b | 7.91% |
| 2026 | $41.1b | 4.57% |
| 2027 | $42.7b | 3.84% |
| 2028 | $44.5b | 4.24% |
| 2029 | $45.8b | 2.85% |
| 2030 | $47.1b | 2.77% |
| 2031 | $48.9b | 3.87% |
| 2032 | $50.9b | 4.22% |
23 Analysts have issued an Mondelez International EBITDA forecast 2025. The average Mondelez International EBITDA estimate is $6.9b . This is 37.23% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.3b 44.86% , the lowest is $6.5b 27.63% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $6.8b | 16.88% |
|---|---|---|
| 2025 | $6.9b | 1.39% |
| 2026 | $7.4b | 6.74% |
| 2027 | $7.9b | 7.02% |
| 2028 | $8.6b | 8.96% |
| 2029 | $9.3b | 7.43% |
| 2030 | $9.7b | 4.21% |
| 2031 | $10.2b | 5.11% |
| 2032 | $10.7b | 4.94% |
EBITDA Margin
| 2024 | 18.79% | 15.51% |
|---|---|---|
| 2025 | 17.66% | 6.04% |
| 2026 | 18.02% | 2.04% |
| 2027 | 18.57% | 3.05% |
| 2028 | 19.42% | 4.58% |
| 2029 | 20.28% | 4.43% |
| 2030 | 20.56% | 1.38% |
| 2031 | 20.81% | 1.22% |
| 2032 | 20.95% | 0.67% |
29 Mondelez International Analysts have issued a net profit forecast 2025. The average Mondelez International net profit estimate is $4.0b . This is 9.57% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.1b 13.79% , the lowest is $3.8b 3.77% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $4.6b | 7.02% |
|---|---|---|
| 2025 | $4.0b | 13.48% |
| 2026 | $4.4b | 9.84% |
| 2027 | $4.8b | 10.12% |
| 2028 | $5.2b | 8.49% |
| 2029 | $5.7b | 8.38% |
| 2030 | $6.2b | 9.31% |
| 2031 | $6.7b | 8.51% |
| 2032 | $7.3b | 8.63% |
Net Margin
| 2024 | 12.65% | 8.10% |
|---|---|---|
| 2025 | 10.14% | 19.86% |
| 2026 | 10.66% | 5.13% |
| 2027 | 11.30% | 6.00% |
| 2028 | 11.76% | 4.07% |
| 2029 | 12.39% | 5.36% |
| 2030 | 13.18% | 6.38% |
| 2031 | 13.77% | 4.48% |
| 2032 | 14.35% | 4.21% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
29 Analysts have issued a Mondelez International forecast for earnings per share. The average Mondelez International EPS is $3.08 . This is 10.00% higher than earnings per share in the financial year 2024. The highest EPS forecast is $3.20 14.29% , the lowest is $2.92 4.29% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $3.42 | 5.52% |
|---|---|---|
| 2025 | $3.08 | 9.94% |
| 2026 | $3.39 | 10.06% |
| 2027 | $3.73 | 10.03% |
| 2028 | $4.05 | 8.58% |
| 2029 | $4.39 | 8.40% |
| 2030 | $4.79 | 9.11% |
| 2031 | $5.20 | 8.56% |
| 2032 | $5.65 | 8.65% |
P/E ratio
| Current | 22.19 | 11.13% |
|---|---|---|
| 2025 | 20.15 | 9.19% |
| 2026 | 18.34 | 8.98% |
| 2027 | 16.66 | 9.16% |
| 2028 | 15.35 | 7.86% |
| 2029 | 14.17 | 7.69% |
| 2030 | 12.96 | 8.54% |
| 2031 | 11.94 | 7.87% |
| 2032 | 10.99 | 7.96% |
Based on analysts' sales estimates for 2025, the Mondelez International stock is valued at an EV/Sales of 2.54 and an P/S ratio of 2.04 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 2.69 | 13.78% |
|---|---|---|
| 2025 | 2.54 | 5.68% |
| 2026 | 2.43 | 4.37% |
| 2027 | 2.34 | 3.70% |
| 2028 | 2.24 | 4.07% |
| 2029 | 2.18 | 2.77% |
| 2030 | 2.12 | 2.70% |
| 2031 | 2.04 | 3.73% |
| 2032 | 1.96 | 4.05% |
P/S ratio
| Current | 2.17 | 17.02% |
|---|---|---|
| 2025 | 2.04 | 5.64% |
| 2026 | 1.95 | 4.37% |
| 2027 | 1.88 | 3.70% |
| 2028 | 1.81 | 4.07% |
| 2029 | 1.76 | 2.77% |
| 2030 | 1.71 | 2.70% |
| 2031 | 1.64 | 3.72% |
| 2032 | 1.58 | 4.05% |
Mondelez International...
Current Mondelez International Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 08 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 06 2025 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Sep 26 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Sep 25 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Jul 31 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 31 2025 |
| Stifel |
Buy
➜
Buy
|
Unchanged | Jul 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 08 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 06 2025 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Sep 26 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Sep 25 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Jul 31 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 31 2025 |
|
Unchanged
Stifel:
Buy
➜
Buy
|
Jul 30 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
